Sarepta Therapeutics
SRPT
#2501
Rank
โ‚น444.78 B
Marketcap
โ‚น4,584
Share price
1.56%
Change (1 day)
-56.46%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): โ‚น22.16 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น1.90 Billion. , an increase over its 2023 earnings that were of -โ‚น44.8 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น22.46 B-150.14%
2023 -โ‚น44.8 Billion-24.62%
2022 -โ‚น59.43 Billion64.69%
2021 -โ‚น36.09 Billion-24.25%
2020 -โ‚น47.64 Billion-22.53%
2019 -โ‚น61.49 Billion96.87%
2018 -โ‚น31.24 Billion645.68%
2017 -โ‚น4.19 Billion-81.81%
2016 -โ‚น23.02 Billion21.47%
2015 -โ‚น18.96 Billion62.04%
2014 -โ‚น11.7 Billion21.26%
2013 -โ‚น9.65 Billion60.93%
2012 -โ‚น6 Billion93.69%
2011 -โ‚น3.1 Billion71.58%
2010 -โ‚น1.81 Billion35.06%
2009 -โ‚น1.34 Billion-11.62%
2008 -โ‚น1.52 Billion-47.02%
2007 -โ‚น2.86 Billion0.38%
2006 -โ‚น2.85 Billion88.3%
2005 -โ‚น1.51 Billion-30.06%
2004 -โ‚น2.16 Billion32.69%
2003 -โ‚น1.63 Billion-25.52%
2002 -โ‚น2.19 Billion64.52%
2001 -โ‚น1.33 Billion50.4%
2000 -โ‚น0.89 Billion26.44%
1999 -โ‚น0.7 Billion8%
1998 -โ‚น0.65 Billion102.7%
1997 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น59.43 B 164.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น13.49 Billion-160.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น27.77 Billion-223.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น7.49 Billion-133.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น20.29 Billion-190.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น31.28 Billion-239.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น71.48 Billion-418.21%๐Ÿ‡บ๐Ÿ‡ธ USA